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Abstract
2q  .Examination was made of the effect of annexin V on Ca movement into large unilamellar vesicles LUV using fura-2,
a calcium-sensitive fluorescent dye. To avoid the possible difficulties relating to the addition of annexin V andror Ca2q in
fura-2-loaded LUV, the burst method was used. LUV, preincubated with rat annexin V in the presence of Ca2q, were
collected by centrifugation and resuspended, and then burst with Triton X-100 in the presence of fura-2. Inward Ca2q
movement across the artificial lipid membrane was measured by determination of fura-2 fluorescence due to the leaked
Ca2q from ruptured LUV. The observed Ca2q signal increased dependent on annexin V and Ca2q concentrations, whereas
bovine serum albumin did not affect this signal up to 1 mM. Thus, annexin V shows Ca2q channel activity in LUV. K201, a
novel 1,4-benzothiazepine, inhibited inward Ca2q movement into LUV caused by annexin V in a dose-dependent manner.
In the presence of 50 nM annexin V and 400 mM Ca2q, 3 mM K201 showed significant inhibition of Ca2q movement due
to annexin V, and 50% inhibition was achieved at 25mM K201. On the other hand, diltiazem had no such effect even at 30
mM. K201 is thus shown to have inhibitory activity on inward Ca2q movement due to annexin V in artificial vesicles and
may prove useful as a probe for elucidating the functions of annexin V in vivo. q 1997 Elsevier Science B.V.
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1. Introduction
Annexin V is a member of the annexin family
which binds to phospholipid and actin, in a Ca2q-de-
w xpendent manner 1,2 . This protein has been sug-
gested to have such actions as anticoagulant activity
w x w x3 , anti-inflammatory activity 4 and inhibition of
w xprotein kinase C 5 in vitro.
Annexin V has been found to express calcium
) Corresponding author. Fax: q81-3-33560441.
w xchannel activity by the patch clamp method 6 , and
its molecular structure as an ion channel model has
w xbeen proposed based on the crystal structure 7 . The
biological roles of annexin V have yet to be fully
determined in vivo, but if a low molecular weight
compound that binds to annexin V and inhibits its
function can be made available, considerable clarifi-
cation in this regard should be possible.
w A novel 1,4-benzothiazepine derivative, 4- 3- 1-
 . 4 x4-benzyl piperidinyl propionyl -7-methoxy-
2,3,4,5-tetrahydro-1,4-benzothiazepine, K201 Fig.
.1 , has been found to have potential for preventing
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Fig. 1. Chemical structure of K201.
w xcardiac cell damage due to calcium overload 8 . It
was also found capable of protecting the myocardium
from damage induced by six hour ischemia using a
w xrat Langendorff model 9 . On the other hand, K201
exhibited an inhibitory effect on binding of cardiac
2q w xannexin V with actin in a Ca -dependent manner 8
and was demonstrated to bind to annexin V by X-ray
crystallography unpublished observation, submitted
.for publication .
In order to clarify the calcium ion channel activity
of annexin V, the present study was conducted to
examine the inhibitory effect of K201 on inward
Ca2q movement across large unilamellar vesicles
 . w x 2qLUV due to annexin V using fura-2 10 , a Ca -
dependent fluorescent agent. The effect of K201 was
w xalso compared with that of diltiazem 11 , a 1,5-ben-
zothiazepine derivative. For this purpose, the burst
method was employed to measure the amount of
influxed Ca2q in the collected LUV after preincuba-
tion with annexin V and Ca2q, to avoid possible
difficulties such as LUV disintegration caused by
annexin V andror Ca2q.
2. Materials and methods
2.1. Purification of annexin V
w xAs in our previous study 12 , annexin V was
purified from the hearts of 50 mature male Wistar
strain rats using a Sephacryl S-300 Pharmacia, Upp-
.  .sala, Sweden column 3.3=55 cm , and then a
DEAE Bio-Gel Agarose Bio Rad Laboratories, Rich-
.  .mond, CA, USA column 1.0=10 cm . Identifica-
tion of annexin V was made by partial amino acid
sequencing. Quantitative protein analysis was con-
ducted according to the modified method of Lowry et
 .al., using bovine serum albumin BSA as a standard
w xprotein 13 .
2.2. Preparation of LUV
LUV were prepared by the procedure of Reeves
w xand Dowben 14 , with modification and by that of
w xBerendes et al. 15 . Briefly, a solution of phos-
phatidylserine and phosphatidylethanolamine wrw
.  .9:1 dissolved in methanolrchloroform vrv 1:2 to
a total volume of 1115 ml was poured into a round
bottom flask. Treatment of the mixture with a rotary
 .evaporator Tokyo-Rikakikai, type N-1N, Tokyo led
to the formation of a dehydrated film under N gas.2
This film, comprised of lipids, was further dehy-
drated for 30 min by the evaporator under water-
saturated nitrogen. After gently pouring 2 ml buffer
wA 180 mM EGTA, 162 mM sucrose, 10 mM HEPES,
 .xpH 7.4 tetramethylammonium hydroxide; TMA into
the flask, the lipid film was saturated with nitrogen
gas and the flask was sealed with a rubber cap and
left to stand at 378C for 2 h to produce LUV. The
multilamellar vesicles were removed by centrifuga-
tion. The LUV solution was centrifuged in a Beck-
man Avanti 30 compact centrifuge at 12 000=g for
10 min at 48C. To the sediment containing LUV,
wdilution buffer B 180 mM EGTA, 160 mM sucrose,
 .x10 mM HEPES, pH 7.4 TMA was added to adjust
the total volume to 100 ml. This procedure was
performed twice, and the suspension of LUV 200
.ml was used to perform at least twenty experiments.
The total lipid concentration of liposomes was esti-
mated as inorganic phosphate by phosphate analysis
w x16 .
2.3. Burst method
The burst method was used to examine inward
Ca2q movement into LUV due to annexin V. To 442
ml dilution buffer B containing ca. 0–450 mM Ca2q,
 .a suspension containing LUV 8 ml and annexin V
 .ca. 0–100 nM 50 ml were added, followed by
preincubation at 268C for 10 min. After adding 400
mM EGTA, the solution was centrifuged at 48C for
10 min at 7000=g to collect LUV. The collected
 .LUV were suspended in buffer B solution 480 ml
containing 1 mM fura-2. After incubation in a cuvette
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 .Fig. 2. Burst method: 1 LUV were added to buffer solution
containing Ca2q and then annexin V with or without reagent was
added. Concentration of phospholipid in LUV suspension was 20
mM. The final amount of phospholipid used in each experiment
y1  .was 0.125 mmol cell . 2 Incubation was conducted at 268C for
10 min. LUV were recollected by centrifugation following the
 .addition of 400 mM EGTA. 3 Resuspended LUV were burst by
addition of 0.2% Triton X-100 in 1 mM fura-2 solution.
at 378C for 1 min, a burst was made with 0.2% Triton
 .  .X-100 10% wrw, 10 ml Fig. 2 . The effect of
 . 2qBSA ca. 0–1000 nM on Ca movement into LUV
was also investigated.
To prove that there is no influence of K201 on the
liposomes, Ca2q-incorporated LUV were made.
Ca2q-incorporated LUV were prepared by addition of
400 mM Ca2q in buffer A at the time of preparation
of LUV. These were incubated with ca. 0–10y4 M
K201 at 268C for 10 min, and then recollected and
burst as above.
The influence of K201 on the ability of annexin V
to bind to liposomes in the presence of Ca2q was
estimated by measurement of the amount of annexin
V binding to LUV incubated in various concentra-
 .tions of K201. LUV containing only buffer A were
incubated with 50 nM annexin V and ca. 0–10y4 M
K201 in the presence of 400 mM Ca2q at 268C for 10
min. Recollected LUV were burst with 0.2% Triton
X-100 and then the concentrations of annexin V were
w xmeasured by ELISA, as previously reported 17 .
Ca2q concentration was measured by a JASCO
CAF-110 fluorescence spectrophotometer Nihon
.Bunkou, Tokyo, Japan . Data were obtained at excita-
tion wavelengths of 340 and 380 nm and at an
emission wavelength of 500 nm. K201 or diltizem at
ca. 0.1–100 mM was first incubated with annexin V
at 268C for 30 min, and then these were added to the
reaction buffer B solution containing LUV, and the
effects of both drugs were examined.
2.4. Materials
Phosphatidylserine, phosphatidylethanolamine,
 .BSA fatty acid free and TMA were obtained from
 .Sigma St. Louis, MO . HEPES and EGTA were
 .from Nacarai Tesque Kyoto , fura-2 from Dojin
 .Laboratories Kumamoto, Japan and Triton X-100
 .from Millipore San Francisco, CA . The reagents
used were K201 Japan Tobacco, Central Pharmaceu-
.tical Research Institute, Osaka, Japan and diltiazem
 .Sigma , which were dissolved in distilled water for
use in the experiments.
2.5. Statistics
Student’s t-test was conducted for statistical analy-
sis of the data; P values less than 0.05 were consid-
ered significant.
3. Results
The amino acid segment of annexin V purified
from rat heart was shown to be YMTIS-
GFQIEETIDR, corresponding to 213–227 of previ-
w xously reported annexin V from human placenta 3 .
Examination of the effects of K201 and diltiazem on
Fig. 3. Effects of K201 and diltiazem on fluorescence intensity in
fura-2 solution. Composition of solution: 180 mM EGTA, 160
 .mM sucrose, 10 mM HEPES, 1 mM fura-2, pH 7.4 TMA . Open
circles: control. Open squares: 100 mM K201. Closed squares:
100 mM diltiazem. Both K201 and diltiazem had no effect on the
fluorescence ratio.
( )N. Kaneko et al.rBiochimica et Biophysica Acta 1330 1997 1–74
 .Fig. 4. A Effects of annexin V on fluorescence intensity. LUV
 .were preincubated with annexin V ca. 0–100 nM in the pres-
2q  .  .ence of Ca 400 mM . B Effects of calcium on fluorescence
 .intensity. LUV were incubated with annexin V 50 nM in the
2q  .presence of Ca ca. 0–450 mM . Closed triangles: Time of
resuspension of LUV. Open triangles: Time of addition of Triton
X-100. An V: Annexin V
fura-2-calcium complex was made by addition of
Ca2q to buffer B solution containing 1 mM fura-2.
The 340r380 fluorescence ratio indicated neither
 .K201 nor diltiazem to have any effect Fig. 3 .
Fluorescence signals due to the leakage of trapped
Ca2q were recognized by the burst of LUV preincu-
bated with annexin V in the presence of Ca2q. The
degree of fluorescence signal emission was depen-
 .Fig. 5. Effects of BSA ca. 0–1000 nM on fluorescence inten-
 .sity. LUV were incubated with BSA ca. 0–1000 nM in the
2q  .presence of Ca 400 mM . Closed triangles: Time of resuspen-
sion of LUV. Open triangles: Time of addition of Triton X-100.
dent on annexin V concentration. When the annexin
V concentration in the incubation solution increased,
the fluorescence ratio increased dose dependently and
reached the maximum at 50 nM in the presence of
2q  .400 mM Ca Fig. 4A . LUV, following preincuba-
tion with 50 nM annexin V, also showed an increase
in fluorescence ratio with Ca2q concentration. Fluo-
rescence ratio reached a plateau at Ca2q concentra-
 .tions higher than 400 mM Fig. 4B . BSA did not
affect this fluorescence signal up to 1 mM in the
2q  .presence of 400 mM Ca Fig. 5 .
The effect of K201 and diltiazem on inward Ca2q
movement into LUV was measured in the presence of
50 nM annexin V and 400 mM Ca2q. K201 was
shown to inhibit inward Ca2q movement dose depen-
 . dently Fig. 6A . Under the same conditions in the
2q.presence of 50 nM annexin V and 400 mM Ca ,
K201 at 0.1 or 1 mM had no significant effect, but
 .  .Fig. 6. A Effects of K201 on fluorescence intensity. B Effects of diltiazem on fluorescence intensity. LUV were incubated with
 . 2q  .annexin V 50 nM and each reagent in the presence of Ca 400 mM . Closed triangles: Time of resuspension of LUV. Open triangles:
Time of addition of Triton X-100. An V: Annexin V.
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Fig. 7. Relationship between fluorescence intensity and concen-
trations of K201 and diltiazem. Open circles: K201, Closed
circles: diltiazem. Horizontal bars show mean" standard error.
 .Each experimental group contained 4 or 5 cases ns4 or 5 .
) ))  .P -0.05, P -0.001 control vs. each group .
Fig. 8. Relationship between concentration of K201 and Ca2q
signal due to bursting of Ca2q-incorporated LUV. Ca2q-incorpo-
rated LUV were incubated with ca. 0–10y4 M K201 at 268C for
10 min.
Fig. 9. Relationship between concentration of K201 and amount
of annexin V binding to LUV. LUV were incubated with 50 nM
annexin V and ca. 0–10y4 M K201 in the presence of 400 mM
Ca2q at 268C for 10 min.
fluorescence ratio decreased significantly at 3 mM
 .and higher Fig. 7 . The dose for 50% inhibition of
inward Ca2q movement was found to be 25 mM.
Diltiazem did not show any effect at 30 mM, and
showed an inhibitory effect only at very high concen-
 .  .trations 100 mM Fig. 6BFig. 7 .
In the experiments using Ca2q-incorporated LUV,
no influence of K201 on the liposomes was recog-
nized. Recollected Ca2q-incorporated LUV incubated
with 0–10y4 M K201 showed almost the same Ca2q
 .signal by burst method Fig. 8 . K201 also had no
influence on the ability of annexin V to bind to
liposomes. The amount of annexin V binding to LUV
in the presence of Ca2q did not change under the
y4  .conditions of 0–10 M K201 Fig. 9 .
4. Discussion
w x w xIn the annexin family, annexin I 18 , II 19 , V
w x w x w x6,7 , VI 20,21 , and VII 22 have been revealed to
have voltage-dependent Ca2q channel activity in vitro
using patch clamp and dipping techniques. There
have been some reports that suggest that annexin V
has Ca2q transport activity, using LUV and fura-2.
Berendes et al. noted annexin V at 25 to 200 nM to
exhibit calcium transport activity using fura-2-incor-
porated LUV, thereby promoting calcium influx in
2q w xthe presence of Ca 15 . On the other hand,
Goossens et al. could detect no Ca2q channel activity
even following the addition of 150 nM recombinant
annexin V and native annexin V purified from human
placenta to LUV in the presence of Ca2q using
fura-2-incorporated LUV, and concluded that annexin
V in the presence of low concentrations of Ca2q
causes disruption of the lipid membrane with conse-
quent leakage of fura-2, rather than inward Ca2q
w xtransport 23 . Views on the functions of annexin V
in experiments using fura-2-incorporated LUV are
thus at variance.
Here, a study was conducted to determine whether
rat native annexin V is capable of inducing inward
Ca2q movement across lipid membranes. Our prelim-
inary study using fura-2-incorporated LUV indicated
that annexin V induces an increase in the fluores-
cence ratio following centrifugation in the presence
of a high concentration of Ca2q. This result suggests
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that a high concentration of Ca2q makes LUV sus-
ceptible to disruption. However, addition of EGTA to
the solution prevented this disruption by centrifuga-
tion. For the purpose of clarifying the effect of
annexin V on inward Ca2q movement into LUV,
usage of fura-2-incorporated LUV as in the previous
w xreports 15,23 would not be suitable, because it
could not be determined whether an increase in fluo-
rescence ratio in solution containing fura-2-incorpo-
rated LUV was due to an increase in inward Ca2q
movement into LUV or due to leakage of fura-2 from
LUV. On the other hand, the burst method as shown
in Fig. 2 reflects the Ca2q content in LUV, which
results from influx from the outside of LUV, so this
method can avoid the artificial results described
above.
w xSince Goossens et al. 23 reported that a very high
2q  .concentration of Ca 2.5 mM and bovine serum
 y1 .albumin 5 g l sabout 80 mM caused a signifi-
cant increase in fluorescence with excitation and
emission wavelengths of 340 and 500 nm using
fura-2-loaded LUV, we measured the effect of BSA
on inward Ca2q movement into LUV by this burst
method. BSA did not show any effect on fluores-
 .cence ratio up to 1 mM Fig. 5 . A high concentration
of proteins such as BSA might cause nonspecific
disturbance of LUV as described by Reeves and
w x w xDowben 14 and Goossens et al. 23 . Therefore, we
used relatively low concentrations of annexin V 0 to
. 2q  .100 nM and Ca 0 to 450 mM in this study to
avoid nonspecific andror artificial disturbance.
After disruption by Triton X-100, the fluorescence
ratio of LUV solution was increased by annexin V
and Ca2q dose dependently as shown in Fig. 4.
Maximum response was achieved at 50 nM annexin
V in the presence of 400 mM Ca2q, and at 400 mM
Ca2q in the presence of 50 nM annexin V. Thus,
native rat annexin V induces Ca2q movement into
LUV and shows calcium influx activity in artificial
phospholipid membrane in vitro.
w xBurger et al. 24 noted the X-ray crystal structure
of annexin V to have features of channel-forming
membrane protein. Recently, we found by protein
X-crystallography that K201 binds with the central
region of annexin V formed by domains II, III, and
IV unpublished observation: submitted for publica-
.tion . K201, thus, shows not only ability to bind to
annexin V but also inhibitory activity on annexin
V-dependent inward Ca2q movement into LUV in a
 .dose-dependent manner Fig. 7 . K201 did not show
 .effects to stabilize or destroy liposomes Fig. 8 and
there was no influence of K201 on the ability of
 .annexin V to bind to liposomes Fig. 9 . Diltiazem, a
1,5-benzothiazepine, did not affect inward Ca2q
movement into LUV even at 30 mM and showed an
inhibitory effect at 100 mM, and hardly bound to the
same site in annexin V as K201 as shown by com-
puter associated drug design method based on X-ray
 .crystallography of annexin V data not shown .
Therefore, inhibition of diltiazem appears to be non-
specific, not being dependent on concentration.
Although K201 has been demonstrated to have a
w xstrong cardioprotective effect 8 , the mechanisms of
this action are unclear at the present time. Annexin V
hardly associates with phosphatidylcholine and sph-
ingomyelin, but it has a high affinity for the acidic
w xphospholipids, such as phosphatidylserine 2 . Since
phosphatidylserine is mainly located in the inner
layer of the plasma membrane, annexin V, which is
an intracellular protein, might reveal its function in
the cytoplasmic site of cells under normal conditions.
Recently, it has been reported that the translocation
of phosphatidylserine from the inner side of the
plasma membrane to the outer layer occurs in abnor-
mal conditions, such as in the early stage of apoptosis
and cell injury, and the annexin V binding site ap-
peared in the outer membrane in these conditions
w x25–27 . On the other hand, we demonstrated that
annexin V is displaced from its ordered distribution
in the plasma membrane in the ischemic heart by
w ximmunohistochemical studies 12 . Furthermore, we
also found that annexin V levels in plasma were
substantially increased in patients with acute myocar-
w xdial infarction 17 ; that is, annexin V is released into
the plasma in some forms of injury. These results
suggest that intrinsic annexin V acts not only in the
inner part of cells but also in the outer membrane in
abnormal conditions. In this study, K201 inhibited
the calcium channel activity of annexin V, and it
acted as a cytoprotective agent in certain abnormal
conditions andror injuries, such as a myofibrillar
w xovercontraction model of isolated rat heart 8 ,
demonstrating myocardial preservation in the rat in
w xvitro 9 . Although the role of annexin V channels in
vivo is unclear at present, it is possible that annexin
V causes deterioration of abnormal cellular functions
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via accelerating inward Ca2q current through its
channel. In order to clarify this hypothesis, further
studies, such as demonstrating the presence of an-
nexin channels in apoptotic and injured cells, are
necessary and K201 might be a good tool as an
inhibitor of this channel.
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